As we at Budding Trends reported last week, the DEA is set to finally accept the recommendation of the U.S. Department of Health and Human Services (HHS) to reschedule marijuana from Schedule I to Schedule III under the...more
5/7/2024
/ Administrative Law Judge (ALJ) ,
Cannabis Products ,
Congressional Review Act ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Final Rules ,
Judicial Review ,
Legislative Agendas ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Notice of Proposed Rulemaking (NOPR) ,
OMB ,
Public Comment ,
Regulatory Agenda ,
Schedule I Drugs ,
State and Local Government
As states around the country continue to liberalize cannabis rules, an increasing number of industries are transitioning into the market — and the next on the horizon may be the hospitality industry.
Not surprisingly,...more
Texas’s cannabis industry can breathe a momentary sigh of relief. Delta-8 THC, the increasingly popular hemp-derived cannabinoid that produces effects similar to Delta-9 THC, has been removed from Texas’s list of Schedule I...more
11/12/2021
/ Administrative Procedure Act ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Centers for Disease Control and Prevention (CDC) ,
Controlled Substances ,
Farm Bill ,
Food and Drug Administration (FDA) ,
Hemp ,
Marijuana Related Businesses ,
State and Local Government ,
Texas ,
THC